华人健康
(301408)
| 流通市值：39.38亿 | | | 总市值：68.80亿 |
| 流通股本：2.29亿 | | | 总股本：4.00亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,420,983,890.57 | 5,486,683,545.91 | 3,892,464,110.99 | 2,503,904,455.17 |
| 营业收入 | 1,420,983,890.57 | 5,486,683,545.91 | 3,892,464,110.99 | 2,503,904,455.17 |
| 二、营业总成本 | 1,306,494,171.94 | 5,115,071,415.63 | 3,664,095,124.7 | 2,350,978,616.8 |
| 营业成本 | 921,664,827.31 | 3,626,995,765.02 | 2,597,540,141.1 | 1,667,169,353.41 |
| 税金及附加 | 7,590,567.66 | 24,886,213.44 | 17,143,139.45 | 10,629,359.88 |
| 销售费用 | 297,095,061.17 | 1,175,139,158.03 | 843,204,258.08 | 538,543,586.27 |
| 管理费用 | 63,139,325.09 | 231,402,054.54 | 164,985,058.11 | 111,357,140.34 |
| 研发费用 | 9,559,255.08 | 29,579,981.52 | 22,553,167.86 | 12,859,028.94 |
| 财务费用 | 7,445,135.63 | 27,068,243.08 | 18,669,360.1 | 10,420,147.96 |
| 其中:利息费用 | 4,171,084.01 | 15,058,755.36 | 10,085,635.95 | 5,298,955.44 |
| 其中:利息收入 | 1,768,551.06 | 10,031,238.21 | 4,767,351.1 | 6,165,679.95 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 0 | - | 0 | 0 |
| 加:投资收益 | 547,530.14 | 5,026,267.16 | 4,548,916.76 | 3,072,405.24 |
| 净敞口套期收益 | 0 | - | - | 0 |
| 汇兑收益 | 0 | - | - | 0 |
| 资产处置收益 | 1,232,204.83 | 3,739,424.49 | 2,803,044.01 | 1,992,603.72 |
| 资产减值损失(新) | -5,375,809.71 | -79,737,162.11 | -11,940,804.15 | -8,592,627.82 |
| 信用减值损失(新) | -2,290,350.11 | -14,739,112.86 | -7,193,622.6 | -5,208,929.19 |
| 其他收益 | 3,169,025.84 | 14,281,370.73 | 9,507,277.39 | 6,176,240.89 |
| 四、营业利润 | 111,772,319.62 | 300,182,917.69 | 226,093,797.7 | 150,365,531.21 |
| 加:营业外收入 | 242,713.32 | 1,225,781.74 | 806,137.36 | 378,817.81 |
| 减:营业外支出 | 1,224,790.64 | 7,017,979.03 | 4,549,202.26 | 3,230,290.8 |
| 五、利润总额 | 110,790,242.3 | 294,390,720.4 | 222,350,732.8 | 147,514,058.22 |
| 减:所得税费用 | 24,706,381.85 | 80,524,088.13 | 50,958,876.99 | 35,828,990.89 |
| 六、净利润 | 86,083,860.45 | 213,866,632.27 | 171,391,855.81 | 111,685,067.33 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 86,083,860.45 | 213,866,632.27 | 171,391,855.81 | 111,685,067.33 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 79,343,522.28 | 191,352,661.67 | 156,726,575.76 | 103,743,088.72 |
| 少数股东损益 | 6,740,338.17 | 22,513,970.6 | 14,665,280.05 | 7,941,978.61 |
| 扣除非经常损益后的净利润 | 77,906,920.42 | 185,407,173.9 | 151,327,450.13 | 100,810,067.04 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.2 | 0.48 | 0.39 | 0.26 |
| (二)稀释每股收益 | 0.2 | 0.48 | 0.39 | 0.26 |
| 八、其他综合收益 | - | 1,400,217.49 | 1,563,598.63 | 1,563,598.63 |
| 归属于母公司股东的其他综合收益 | - | 1,400,217.49 | 1,563,598.63 | 1,563,598.63 |
| 九、综合收益总额 | 86,083,860.45 | 215,266,849.76 | 172,955,454.44 | 113,248,665.96 |
| 归属于母公司股东的综合收益总额 | 79,343,522.28 | 192,752,879.16 | 158,290,174.39 | 105,306,687.35 |
| 归属于少数股东的综合收益总额 | 6,740,338.17 | 22,513,970.6 | 14,665,280.05 | 7,941,978.61 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-25 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |